Metformin functions through a gut microbiome–bile acid–farnesoid X receptor axis to lower glucose in type 2 diabetes, revealing a new therapeutic target in this disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sterne, J. Maroc Med. 36, 1295–1296 (1957).
Karlsson, F. H. et al. Nature 498, 99 (2013).
Napolitano, A. et al. PLoS ONE 9, e100778 (2014).
Sun, L. et al. Nat. Med. https://doi.org/10.1038/s41591-018-0222-4 (2018).
Chow, M. D., Lee, Y.-H. & Guo, G. L. Mol. Aspects Med. 56, 34–44 (2017).
Chiang, J. Y. L. et al. Dig. Dis. 35, 241–245 (2017).
Foretz, M. et al. J. Clin. Invest. 120, 2355–2369 (2010).
Mueller, M. et al. J. Hepatol. 62, 1398–1404 (2015).
Lindor, K. D. et al. Hepatology 39, 770–778 (2004).
Fang, S. et al. Nat. Med. 21, 159–165 (2015).
Pathak, P. et al. Hepatology 68, 1574–1588 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Guo, G.L., Xie, W. Metformin action through the microbiome and bile acids. Nat Med 24, 1789–1790 (2018). https://doi.org/10.1038/s41591-018-0273-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-018-0273-6
This article is cited by
-
Gut Microbiota Dysbiosis in Human Obesity: Impact of Bariatric Surgery
Current Obesity Reports (2019)